Top Story
-
Health Tech, Hospitals, Providers
Intermountain Health CISO: The Industry Needs Better Transparency After Cyberattacks
After a healthcare cyberattack, the impacted organization often doesn’t want to divulge a lot of information, Intermountain Health CISO Erik Decker said last week at HIMSS. However, he thinks healthcare organizations should be more transparent with their peers after an attack because “no one system operates independent of everybody else.”
-
The Vibe at Vive: Homethrive
Dave Jacobs, co-founder of Homethrive, shared details of how his company supports caregivers.
-
Consumer / Employer, Health Tech
Milu Health Raises $4.8M for AI-Driven Health Savings Platform
Milu Health’s $4.8 million seed round was led by Andreessen Horowitz (a16z) Bio + Health and included participation from BoxGroup, PagsGroup and 81 Collection.
-
Healthcare Docket: Feds and States Move to Curb Private Equity’s Takeover of Healthcare
Will American healthcare go the way of the banking sector’s consolidation into a handful of all-powerful titans?
-
With MS & Fibrosis Trials Planned, J&J-Partnered Contineum Now Preps for IPO
Contineum Therapeutics, which emerged from a Verant Ventures startup creation engine, has filed paperwork for an IPO. The biotech’s clinical-stage pipeline spans multiple sclerosis, idiopathic pulmonary fibrosis, and depression.
-
How Data and AI Help Pharma Sales Teams Better Market Precision Genetic Drugs
As GenAI and other technologies advance the speed of development and the precision of drugs, pharma commercial teams need to make sure they are harvesting the right data with the right AI tools in order to ultimately reach the right patients.
-
Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet
Generic drugs are the pharmaceutical products mainly affected by the missile attacks disrupting shipping in the Red Sea. While the extra costs borne by drug companies aren’t causing an immediate spike in product prices, experts say they’ll eventually be factored into prices if the attacks become a long-term problem.
-
Artificial Intelligence, Health Tech, Providers
6 HIMSS Announcements You Don’t Want to Miss
This year’s HIMSS conference featured a variety of news announcements — from acquisitions to new product launches to advanced partnerships. In this list, MedCity News compiled short summaries for six of the conference’s most notable announcements.
-
Should the DOJ Break Up UnitedHealth Group?
The U.S. Department of Justice has reportedly recently launched an antitrust investigation of UnitedHealth Group, which begs the question of whether the healthcare giant should be broken up. Experts have varying opinions.
-
MedCity Influencers, Nurses, Policy, Providers
Leaders Must Better Support Military Nurses to Attract More Students to the Armed Services
When you are a military nurse, you’re not just a clinical professional, you are also a soldier. Those roles take sacrifice, resilience, and courage. I urge leaders and policymakers to consider solutions to the crisis, including creating better incentives that will bolster the pipeline of students pursuing careers as military nurses.
-
Consumer / Employer, Health Tech
Solera Health, Aon Join Forces to Simplify Employee Healthcare
Solera Health and Aon are collaborating to help employers manage point solution fatigue, engage members and measure ROI.
-
Artificial Intelligence, Health Tech
Hackensack Meridian Health CEO: These 4 Priorities Should Guide AI Strategy
During a keynote address at HIMSS, Hackensack Meridian Health CEO Robert Garrett outlined four priorities that should guide healthcare organizations’ AI strategies. He said that healthcare leaders need to take care to ensure their AI efforts seek to address one if not all of these.
-
A Startup’s Flexibility With ADC Cancer Drugs Attracts €128M for Clinical Trials
Tubulis’s next-generation ADC cancer drugs are designed to overcome limitations of currently available therapies in this drug class. The new financing will support clinical trial plans, but first, preclinical proof-of-concept data will be presented during the American Association for Cancer Research annual meeting.
-
Gonorrhea, Chlamydia and Syphilis Rates Are Exploding. Here’s How AI Can Help.
The emergence of artificial intelligence (AI) offers a glimmer of hope in the fight against STDs and has the power to revolutionize the landscape of STD detection, treatment, and prevention.